Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
NCT07061288

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

Led by Bristol-Myers Squibb · Updated on 2025-12-22

48

Participants Needed

8

Research Sites

110 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia

CONDITIONS

Official Title

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have a primary diagnosis of schizophrenia confirmed by psychiatric evaluation using DSM-5-TR criteria and MINI version 7.0.2
  • Participants must have a PANSS total score of 80 or less and a CGI-S score of 4 or less at both screening and baseline
  • Participants must have a body mass index between 18 and 40 kg/m2
  • Participants must be willing and able to discontinue all antipsychotic medications before baseline and comply with all protocol requirements
Not Eligible

You will not qualify if you...

  • Participants must not have newly diagnosed schizophrenia or a first treated episode of schizophrenia
  • Participants must not have any other DSM-5-TR disorder diagnosed within the past 12 months such as major depressive disorder or bipolar disorder
  • Participants must not have a history of alcohol or drug use disorder within the past 12 months or any clinically significant disease that would affect safety or study results
  • Participants must not be at risk for suicidal behavior
  • Female participants must not be pregnant or breastfeeding
  • Other protocol-defined inclusion/exclusion criteria apply

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Collaborative Neuroscience Research, LLC

Los Alamitos, California, United States, 90720-3118

Actively Recruiting

2

Research Centers of America ( Hollywood )

Hollywood, Florida, United States, 33024

Actively Recruiting

3

Innovative Clinical Research, Inc.

Miami Lakes, Florida, United States, 33016

Actively Recruiting

4

Atlanta Center for Medical Research

Atlanta, Georgia, United States, 30331

Actively Recruiting

5

CenExel iResearch, LLC

Decatur, Georgia, United States, 30030

Actively Recruiting

6

Uptown Research Institute

Chicago, Illinois, United States, 60640

Actively Recruiting

7

Hassman Research Institute Marlton Site

Marlton, New Jersey, United States, 08053

Actively Recruiting

8

Community Clinical Research

Austin, Texas, United States, 78754

Actively Recruiting

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

F

First line of the email MUST contain the NCT# and Site#

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia | DecenTrialz